BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25526961)

  • 1. Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.
    Ohmoto M; Takahashi T; Kubota Y; Kobayashi S; Mitsumoto Y
    BMC Genet; 2014 Dec; 15():151. PubMed ID: 25526961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A DRD2 and ANKK1 haplotype is associated with nicotine dependence.
    Voisey J; Swagell CD; Hughes IP; van Daal A; Noble EP; Lawford BR; Young RM; Morris CP
    Psychiatry Res; 2012 Apr; 196(2-3):285-9. PubMed ID: 22382052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the SLC6A3 VNTR (DAT) and DRD2/ANKK1 Taq1A polymorphisms with alcohol dependence in a population from northeastern Brazil.
    Vasconcelos AC; Neto Ede S; Pinto GR; Yoshioka FK; Motta FJ; Vasconcelos DF; Canalle R
    Alcohol Clin Exp Res; 2015 Feb; 39(2):205-11. PubMed ID: 25684044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of dopamine pathway gene score, nicotine dependence and smoking cessation in a rural male population of Shandong, China.
    Li S; Wang Q; Pan L; Li H; Yang X; Jiang F; Zhang N; Han M; Jia C
    Am J Addict; 2016 Sep; 25(6):493-8. PubMed ID: 27490263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy.
    Stapleton JA; Sutherland G; O'Gara C; Spirling LI; Ball D
    Pharmacogenet Genomics; 2011 Aug; 21(8):447-53. PubMed ID: 21540761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.
    Sieminska A; Buczkowski K; Jassem E; Niedoszytko M; Tkacz E
    BMC Med Genet; 2009 Sep; 10():92. PubMed ID: 19761593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers.
    Perkins KA; Lerman C; Coddington S; Jetton C; Karelitz JL; Wilson A; Jennings JR; Ferrell R; Bergen AW; Benowitz NL
    Behav Pharmacol; 2008 Sep; 19(5-6):630-40. PubMed ID: 18690117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits.
    Kazantseva A; Gaysina D; Malykh S; Khusnutdinova E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1033-40. PubMed ID: 21354244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers.
    Breitling LP; Müller H; Illig T; Rujescu D; Winterer G; Dahmen N; Nitz B; Raum E; Rothenbacher D; Brenner H
    Pharmacogenomics; 2011 Aug; 12(8):1099-106. PubMed ID: 21806388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood.
    Perkins KA; Lerman C; Grottenthaler A; Ciccocioppo MM; Milanak M; Conklin CA; Bergen AW; Benowitz NL
    Behav Pharmacol; 2008 Sep; 19(5-6):641-9. PubMed ID: 18690118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
    Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate analysis of dopaminergic gene variants as risk factors of heroin dependence.
    Vereczkei A; Demetrovics Z; Szekely A; Sarkozy P; Antal P; Szilagyi A; Sasvari-Szekely M; Barta C
    PLoS One; 2013; 8(6):e66592. PubMed ID: 23840506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers.
    Radwan GN; El-Setouhy M; Mohamed MK; Hamid MA; Azem SA; Kamel O; Israel E; Loffredo CA
    Nicotine Tob Res; 2007 Dec; 9(12):1325-9. PubMed ID: 18058350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence.
    Laucht M; Becker K; Frank J; Schmidt MH; Esser G; Treutlein J; Skowronek MH; Schumann G
    J Am Acad Child Adolesc Psychiatry; 2008 Jun; 47(6):673-681. PubMed ID: 18434921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective association of dopamine-related polymorphisms with smoking cessation in general care.
    Breitling LP; Twardella D; Hoffmann MM; Witt SH; Treutlein J; Brenner H
    Pharmacogenomics; 2010 Apr; 11(4):527-36. PubMed ID: 20350135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DRD2/ANKK1 TaqIA and SLC6A3 VNTR polymorphisms in alcohol dependence: association and gene-gene interaction study in a population of Central Italy.
    Mignini F; Napolioni V; Codazzo C; Carpi FM; Vitali M; Romeo M; Ceccanti M
    Neurosci Lett; 2012 Aug; 522(2):103-7. PubMed ID: 22698582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.
    Pérez-Rubio G; López-Flores LA; Ramírez-Venegas A; Noé-Díaz V; García-Gómez L; Ambrocio-Ortiz E; Sánchez-Romero C; Hernández-Zenteno RJ; Sansores RH; Falfán-Valencia R
    Gene; 2017 Sep; 628():205-210. PubMed ID: 28734893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.
    Styn MA; Nukui T; Romkes M; Perkins K; Land SR; Weissfeld JL
    Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):254-61. PubMed ID: 18563706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample.
    Huang W; Payne TJ; Ma JZ; Beuten J; Dupont RT; Inohara N; Li MD
    Neuropsychopharmacology; 2009 Jan; 34(2):319-30. PubMed ID: 18354387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.